BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

  November 14, 2024

   · 

  2 min read
• Press Releases

  Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

  November 14, 2024

   · 

  7 min read
• Press Releases

  PHAXIAM Reports Third-Quarter 2024 Financial Information

  November 14, 2024

   · 

  4 min read
• Press Releases

  Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds

  November 14, 2024

   · 

  5 min read
• Press Releases

  BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

  November 14, 2024

   · 

  3 min read
• Press Releases

  Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates

  November 14, 2024

   · 

  11 min read
• Press Releases

  Alumis Reports Third Quarter 2024 Financial Results and Highlights Recent Achievements

  November 14, 2024

   · 

  10 min read
• Press Releases

  Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

  November 14, 2024

   · 

  11 min read
• Press Releases

  Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

  November 14, 2024

   · 

  11 min read
• Press Releases

  Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

  November 14, 2024

   · 

  13 min read